DNA Topoisomerases and Cancer
Book information
Description
DNA topoisomerases represent an essential family of DNA processing enzymes and a large number of topoisomerase inhibitors are used clinically for the treatment of various human cancers. Novels drugs are in clinical development both against type I and type II topoisomerases. The book will include basic biochemical and structural reviews for the cancer-relevant topoisomerases. It will describe how topoisomerase dysfunctions can damage the genome and increase the risk of cancers, and the involvement of topoisomerases in programmed cell death. The book will also present the various topoisomerase inhibitors in clinical use and development and their molecular and cellular mechanisms of action.
Similar books
Natural Killer T cells: Balancing the Regulation of Tumor Immunity
2012 · PDF
DNA Topoisomerases and Cancer
2012 · PDF
Modeling Tumor Vasculature: Molecular, Cellular, and Tissue Level Aspects and Implications
2012 · PDF
Insulin Resistance and Cancer: Epidemiology, Cellular and Molecular Mechanisms and Clinical Implications
2011 · PDF
The Tumor Microenvironment
2010 · PDF
Vascular Disruptive Agents for the Treatment of Cancer
2010 · PDF
Molecular Genetics of Liver Neoplasia
2011 · PDF
Epidemiology, Pathogenesis, and Prevention of Head and Neck Cancer
2010 · PDF